An alpha-MSH analogue mimics ischemic preconditioning in the heart
Von: Kofi (kofi@anon.un) [Profil]
Datum: 01.11.2009 04:41
Message-ID: <kofi-9D16F1.21412531102009@news.east.earthlink.net>
Newsgroup: alt.support.crohns-colitis alt.support.ibssci.life-extension alt.baldspot
Datum: 01.11.2009 04:41
Message-ID: <kofi-9D16F1.21412531102009@news.east.earthlink.net>
Newsgroup: alt.support.crohns-colitis alt.support.ibssci.life-extension alt.baldspot
This research implies those with overactive PDE's or defects in MC1R signaling (like redheads) might be more prone to ischemia. It's also got me wondering about the link between redheads and Parkinson's. Peptides. 2009 Sep 30; The peptide NDP-MSH induces phenotype changes in the heart that resemble ischemic preconditioning. Catania A, Lonati C, Sordi A, Leonardi P, Carlin A, Gatti S. Center for Preclinical Investigation, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy. alpha-Melanocyte-stimulating hormone (alpha-MSH) is a pro-opiomelanocortin (POMC)-derived peptide that exerts multiple protective effects on host cells. Previous investigations showed that treatment with alpha-MSH or synthetic melanocortin agonists reduces heart damage in reperfusion injury and transplantation. The aim of this preclinical research was to determine whether melanocortin treatment induces preconditioning-like cardioprotection. In particular, the plan was to assess whether melanocortin administration causes phenotype changes similar to those induced by repetitive ischemic events. The idea was conceived because both ischemic preconditioning and melanocortin signaling largely depend on cAMP response element binding protein (CREB) phosphorylation. Rats received single i.v. injections of 750mug/kg of the alpha-MSH analogue Nle(4),DPhe(7)-alpha-MSH (NDP-MSH) or saline and were sacrificed at 0.5, 1, 3, or 5h. Western blot analysis showed that rat hearts expressed melanocortin 1 receptor (MC1R) protein. Treatment with NDP-MSH was associated with early and marked increase in interleukin 6 (IL-6) mRNA. This was followed by signal transducer and activator of transcription 3 (STAT3) phosphorylation and induction of suppressor of cytokine signaling 3 (SOCS3). There were no changes in expression of other cytokines of the IL-6 family. Expression of IL-10, IL-1beta, and TNF-alpha was likewise unaltered. In hearts of rats treated with NDP-MSH there was increased expression of the orphan nuclear receptor Nur77. The data indicate that NDP-MSH induces phenotype changes that closely resemble ischemic preconditioning and likely contribute to its established protection against reperfusion injury. In addition, the increased expression of Nur77 and SOCS3 could be part of a broader anti-inflammatory effect. PMID: 19799952 perinatal hypoxic-ischemic (HI; neonatal HI encephalopathy) brain injury is a major cause of permanent neurological dysfunction in children; 24-hour carotid-artery ligation preconditioning established by delaying the onset of hypoxia for 24 hours after permanent unilateral carotid ligation rats markedly diminished the cerebral injury; this carotid-artery ligation preconditioning in neonatal rats involves CREB; ligation of the carotid artery 24 hours before hypoxia provided complete neuroprotection and produced improved performance on the Morris water maze compared with ligation performed 1 hour before hypoxia; carotid artery ligation 6 hours before hypoxia produced intermediate benefit; the 24-hour carotid-artery ligation preconditioning caused a robust and sustained activation of CREB on its phosphorylation site on Ser133; i.c.v. antisense CREB oligodeoxynucleotides significantly reduced the 24-hour carotid-artery ligation-induced neuroprotection effects by decreasing CREB expressions; activation of the cAMP-CREB signal with PDE4 inhibitor rolipram 24 hours before hypoxia protected rat pups at behavioral and pathological levels by sustained increased CREB phosphorylation [PMID 15470752][ Auf dieses Posting antworten ]
